Hypertension in pregnancy

Nephron

Volumn 76, Issue 3, 1997, Pages 254-263

  Bernheim, J ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Endothelial cells; Hypertension; Physiology pathophysiology; Preeclampsia; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; ARGININE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; LABETALOL; METHYLDOPA; NIFEDIPINE; NITRIC OXIDE; PROSTACYCLIN; THROMBOXANE A2;

ADULT; ANIMAL MODEL; ARTICLE; CASE REPORT; CLINICAL FEATURE; ECLAMPSIA; ENDOTHELIUM; FEMALE; HEMODYNAMICS; HUMAN; KIDNEY DISEASE; MATERNAL HYPERTENSION; NONHUMAN; PATIENT CARE; PREECLAMPSIA; PRIORITY JOURNAL; RAT;

EID: 0030796955     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190189     Document Type: Article

References (54)

1. Saflias Af, Olson DR, Franks A, et al: Epidemiology of preeclampsia and eclampsia in the United States 1979-1986. Am J Obstet Gynecol 1990; 163:460.
2. Barron WM, Murphy MB, Lindheimer MD: Management of hypertension during pregnancy; in Laragh GH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis and Management, New York, Raven, 1990. pp 1809-1827.
3. Lindheimer MD, Katz AI: Preeclampsia: Pathophysiology, diagnosis and treatment, Annu Rev Med 1989:40:233-250.
4. Pirani BBK, Campbell DM, MacGillivray I: Plasma volume in normal first pregnancy, J Obstet Gvnaecol Br Commonw 1963:80:884-887.
5. Rovinsky JJ, JatTin H: Cardiovascular haemo-dynantics in pregnancy, II, Cardiac output and left ventricular work in multiple pregnancy, Am J Obstet Gynecol 1966.95:781-786.
6. Cheslcy LC, Talledo E, Bolder CS, Zuspan FP: Vascular reactivity to angiotensin II and norepinephrine in pregnant and non-pregnant women, Am J Obstet Gynecol 1965:52:2682-2689.
7. Benjamin N, Rynter J, Todd SD, Ritter JM: Sensitivity to All of forearm resistance vessels in pregnancy, Br J Clin Pharmacol 1991:32: 523-525.
8. Kovatz S, Rathaus M, Ben Aderet N, Bemheim J: Increased renal prostaglandins in normal pregnancy and in pregnancy with hypertension, Nephron 1985:32:239-243.
9. Bemheim J, Shapira J, David F, et al: Renal prostaglandins Ei and F;„ throughout normal human pregnancy, Eur J Clin Invest 1986:16: 113-116.
10. Gallery EDM, Hunyoer SM, Gyory AZ: Plasma volume contraction: A significant factor in both pregnancy associated hypertension (preeclampsia) and chronic hypertension in pregnancy, Q J Med 1979:48:593-602.
11. Kovatz S, Arber I, Korzets Z, Rathaus M, Ben Aderet N, Bemheim J: Urinary kallikrein in normal pregnancy, pregnancy with hypertension and toxemia, Nephron 1985;40:48-51.
12. Gant NF, Daley GI, Cjand S, Whalley PJ, MacDonald PC: A study of angiotensin pressor response throughout printigravid pregnancy, J Clin Invest 1973;52:2682-2689.
13. Kincaid-Smith P: The renal lesion of preeclampsia revisited, Am J Kidney Dis 1991:17: 144-148.
14. Robertson WB, Brosens I, Dixon G: Uteroplacental vascular pathology, Eur J Obstet Gynecol Reprod Biol 1975;5:47-65.
15. Kincaid-Smith PS, Fairley KF: Morphological changes in preeclampsia: in Kincaid-Smith PS, Fairley KF (eds): The Kidney and Hypertension in Pregnancy, Edinburgh, Churchill Livingstone 1993. p 25.
16. Kincaid-Smith P: Participation of intravascu-lar coagulation in the pathogenesis of glomerular and vascular lesions, Kidncv Int 1975:7: 242-253.
17. Kincaid-Smith PS, North RA, Becker GJ, et al: Proteinuria during pregnancy; in Andrcucci VE (ed): The Kidney in Pregnancy, Boston, NijhofT, 1985. p 133.
18. Vane JR, Anggard EE, Bolting RM: Regulatory functions of the vascular endothelium, N Engl J Med 1990;323:27-36.
19. Roberts JM, Taylor RN, Musci TJ, et al: Preeclampsia: An endothelial cell disorder, Am J Obstet Gynecol 1989:161:1200-1204.
20. Walsh SW: Prccclampsia: An endothelial cell disorder, Am J Obstet Gynecol 1989:161: 1200-1204.
21. Schiff E, Pclcg E, Goldcnberg M, et al: The use of aspirin to prevent pregnancy induced hypertension and lower the ratio of thromboxane A> to prostacyclin in relatively high risk pregnancies, N Engl J Med 1989;321:351-356.
22. Vallance P, Collier J, Moncada S: Effects of endoihelium-dcrived nitric oxide on peripheral arteriolar tone in man, Lancet 1989;2:997-1000
23. Haynes WG, Noon JP, Walker BR, Webb DJ: Inhibition of nitric oxide synthesis increases blood pressure in healthy humans, J Hypertens 1993:11:1375-1380.
24. Podjamv E, Mandelbaum A, Bemheim J: Nitric oxide and pregnancy, Nephrol Dial Transplant 1994:9:1527-1529.
25. Conrad KP, Joffe GM, Kruszyna H, et al: Identification of increased nitric oxide biosynthesis during pregnancv in rats, FASF, B J 1993:7: 566-571.
26. Weiner CP, Liu KZ, Thompson LP, Herrig JE, Chestnut DH: Effect of pregnancy on endothelium and smooth muscle: Their role in reduced adrenergic sensitivity, Am J Physiol 1991:261: H1275-H1283.
27. McCarthy AL, Woolfson RG, Raju SK, Poston L: Abnormal endothelial cell function of resistance arteries from women with preeclampsia, Am J Obstet Gynecol 1993:168:1323-1330.
28. Baylis C, Engels K: Adverse reactions between pregnancy and a new model of systemic hypertension produced by chronic blockade of endothelial-derived relaxing factor in the rat, Clin Exp Hypertens [B] 1992:11:117-119.
29. Yallampalli C, Garfield RE: Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia, Am J Obstet Gynecol 1993; 169:1316-1320.
30. Podjamy E, Pomeranz A, Ratliaus M, Green J, Gonen O, Shamir R, Bemheim J: EfTect of /,-arginine ircatmcnl in pregnant rats with Adria-mvcin nephropathy, Hypcrtcns 1994; 12:517-524.
31. Davison JM: Renal disorders: in Calder AA, Dunlop W(eds): High Risk Pregnancy, Oxford, Butterworth-Heinemann, 1992. p 190.
32. Baylis C: The mechanism of the increase of glomerular filtration rate in the twelve day pregnant rat, J Physiol 1980:305:405-414.
33. Brenner BM, Meyer TW, Hostcttcr TH: Dietary protein intake and the progressive nature of kidney disease, The role of hemodynamical-ly mediated injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation and intrinsic renal disease, N Engl J Med 1982;307:652-655.
34. Baylis C: Immediate and long term effects of pregnancy on glomerular function in the SHR, Am J Physiol 1989;257:F1140-F1145.
35. Baylis C, Reese K, Wilson CB: Glomerular effects of pregnancy in a model of glomerulonephritis in the rat, Am J Kidney Dis 1989:14: 452-460.
36. Podjamy E, Bemheim J, Rathaus M, Pomeranz A, Tovbin D, Shapira J, Bemheim J: Adria-mycin nephropathy: A model to study effects of pregnancy on renal disease in rats, Am J Physiol 1992;263:FD711-FD715.
37. Pomeranz M, Podjarny E, Bemheim J, et al: Effect of recurrent pregnancies on the evolution of Adriamycin nephropathy, Nephrol Dial Transplant 1995;10:2049-2053.
38. Bemheim J, Podjarny E, Pomeranz A, et al: Pregnancy induced hypertension in rats with early Adriamycin nephropathy, Nephrol Dial Transplant 1994;S3:13-16.
39. Rathaus M, Podjamy E, Pomeranz A, Green J, Bemheim J: Adriamycin related hypertension in pregnant rats: Response to a thromboxane receptor antagonist, Clin Sci 1995:88:623-627.
40. Podjarny E, Rathaus M, Bcrnheim J, et al: Cap-topril, but not diltiazem, favorably affects the course of early chronic renal disease in rats, Nephron 1990;55:196-202.
41. Podjamy E, Haskia A, Pomeranz A, et al: Effect of diltiazem and methyldopa on gestation related renal complications in rats with Adriamycin nephrosis, Relationships to glomerular prostanoid synthesis, Nephrol Dial Transplant 1995;10:1598-1602.
42. Rathaus M, Podjarny E, Green J, Bemheim J: Role of nitric oxide in the exaggerated vasocon-strictory response to noradrenaline induced by low Adriamycin in the mesenteric bed of pregnant rats, J Am Soc Nephrol 1995;6:668.
43. Working group on high blood pressure in pregnancy and the national high blood pressure program coordinating committee: National high blood pressure program working group report on high blood pressure in pregnancy, Am J Obstet Gynecol 1990:163:1683-1712.
44. Taufield PA, Ales K, Resnick EM, et al: Hypo-calciuria in preeclampsia, N Engl J Med 1987; 316:715-718.
45. Bar J, Wittneberg C, Hod M, Boner G: Is the presence of white coat hypertension during pregnancy indicative of outcome, pers, com-mun
46. Erman A, Ncri A, Sharoni R, et al: Enhanced urinary albumin excretion after 35 weeks of gestation and during labour in normal pregnancy, Scand J Clin Lab Invest 1992:52:409-413.
47. Dekker GA, De Vries JIP, Doclitzsch PM, et al: Underlying disorders associated with severe carly-onsct prccclampsia, Am J Obstet Gynecol 1995;173:1042-1048.
48. Greer IA: Hypertension: in Colder AA, Dunlop W (eds): High Risk Pregnancy, Oxford, Redwood, Butterworth-Heinemann, 1992. p 59.
49. CLASP collaborative study, CLASP: A randomised trial of low dose aspirin for the prevention and treatment of precclampsia among 9364 pregnant women, Lancet 1994:343:619-629.
50. Greer IA: Hypertension: in Colder AA, Dunlop W (eds): High Risk Pregnancy, Oxford, Redwood, Butterworth-Heinemann, 1992. p 69.
51. Kitridou RC, Mintz G: The mother in SLE; in Wallace DJ, Mahn BH (eds): Wallace-Dubois’ Lupus Erythematosus, ed 4. Malvern, Lea &Febiger, 1993. p 487-515.
52. Ashcrson RA, Khamashta MA, Hughes GRV: Hypertension and the antiphospholipid syndrome, Clin Exp Rheumatol 1993:11:465-467.
53. Lacueva J, Enriquez R, Cabezuclo JB, ct al: Acute renal failure as first clinical manifestation of the primary antiphospholipid syndrome, Nephron 1993;64:479-480.
54. Taylor PV, Shevvow SM, Redman CWG: Precclampsia and antiphospholipid antibody, Br J Obstet Gynecol 1991;98:604-606.